Breaking News
6 hours ago
Vaibhavi M.
ORIC Pharmaceuticals advances rinzimetostat to Phase 3 in prostate cancer after strong Phase 1b data, selecting 400 mg dose for Himalayas-1 trial in mCRPC patients
Vaibhavi M.
Thermo Fisher Scientific launches Glacios 3 Cryo-TEM with enhanced imaging and AI workflows to advance structural biology research and improve lab accessibility for drug discovery studies
Vaibhavi M.
Tarsus Pharmaceuticals initiates Phase 2 Calliope trial of TP-05 to prevent Lyme disease by killing infected ticks, evaluating safety and efficacy in at-risk adults across the US
Vaibhavi M.
Milestone Pharmaceuticals secures Express Scripts formulary coverage for CARDAMYST nasal spray, expanding access to self-administered PSVT treatment for commercially insured patients
Simantini Singh Deo